VCS
PFE icon

Vaughan & Co Securities’s Pfizer PFE Stock Holding History

Vaughan & Co Securities’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$433K Sell
15,411
-433
-3% -$11.5K 0.22% 46
2025
Q4 		$395K Sell
15,844
-495
-3% -$12.5K 0.2% 45
2025
Q3 		$416K Sell
16,339
-10,453
-39% -$258K 0.22% 46
2025
Q2 		$649K Sell
26,792
-74
-0.3% -$1.73K 0.37% 32
2025
Q1 		$681K Hold
26,866
– – 0.42% 33
2024
Q4 		$713K Sell
26,866
-289
-1% -$7.84K 0.43% 31
2024
Q3 		$786K Sell
27,155
-415
-2% -$12.1K 0.46% 28
2024
Q2 		$771K Buy
27,570
+8,370
+44% +$230K 0.49% 21
2024
Q1 		$533K Sell
19,200
-1,718
-8% -$47.7K 0.34% 44
2023
Q4 		$602K Buy
20,918
+8,480
+68% +$256K 0.4% 41
2023
Q3 		$413K Hold
12,438
– – 0.31% 46
2023
Q2 		$456K Hold
12,438
– – 0.32% 47
2023
Q1 		$507K Buy
12,438
+381
+3% +$16.5K 0.38% 46
2022
Q4 		$618K Sell
12,057
-298
-2% -$14.3K 0.49% 36
2022
Q3 		$541K Sell
12,355
-48
-0.4% -$2.33K 0.47% 37
2022
Q2 		$650K Hold
12,403
– – 0.52% 32
2022
Q1 		$642K Sell
12,403
-446
-3% -$23.1K 0.44% 38
2021
Q4 		$759K Sell
12,849
-336
-3% -$16.6K 0.51% 23
2021
Q3 		$567K Sell
13,185
-211
-2% -$9.35K 0.42% 37
2021
Q2 		$525K Hold
13,396
– – 0.39% 38
2021
Q1 		$485K Hold
13,396
– – 0.39% 39
2020
Q4 		$493K Sell
13,396
-1,072
-7% -$39.3K 0.44% 26
2020
Q3 		$504K Sell
14,468
-483
-3% -$16.9K 0.53% 22
2020
Q2 		$464K Hold
14,951
– – 0.51% 28
2020
Q1 		$463K Hold
14,951
– – 0.59% 21
2019
Q4 		$556K Buy
+14,951
New +$533K 0.5% 34

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Vaughan & Co Securities's PFE Position: Q1 2026 in Review

Vaughan & Co Securities reduced its Pfizer (PFE) stake by 2.7% in Q1 2026, selling an estimated $11.5K and leaving 15,411 shares worth $433K. The position accounts for 0.22% of the portfolio, ranked #46.

Vaughan & Co Securities first reported a position in PFE in Q4 2019 and has held it in 26 quarters since. The position peaked at $786K in Q3 2024. 2,934 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Vaughan & Co Securities held 15,411 shares of Pfizer worth $433K as of Q1 2026.
  • Vaughan & Co Securities sold 433 Pfizer shares in Q1 2026, an estimated $11.5K.
  • Pfizer made up 0.22% of Vaughan & Co Securities's portfolio in Q1 2026, its #46 holding.
  • Vaughan & Co Securities first reported a position in Pfizer in Q4 2019 and has held it in 26 quarters since.
  • Vaughan & Co Securities's Pfizer position peaked at $786K in Q3 2024.
  • 2,934 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Vaughan & Co Securities's 13F filing for Q1 2026, filed 27 Apr 2026.